MirImmune mirimmunebio.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

MirImmune is a biopharmaceutical company focusing on the development of immunotherapies for cancer by combining two approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies.

MirImmune is a biopharmaceutical company focusing on the development of immunotherapies for cancer by combining two approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies.

Company (Acquired)

Phone:

Fax:

Cambridge Biolabs, One Kendall Square
Building 200, Suite 2203
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MirImmune $0M Oct 13, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MirImmune Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Immunotherapy of cancer Dec 02, 2014 Application